The company has also achieved selective degradation of ARID1B and plans to provide updates on this and other programs, including selective CBP and EP300 degraders, in 2025. Foghorn reported a ...

First-in-class oral selective SMARCA2 (BRM) inhibitor FHD-909 (LY4050784) continues enrollment in Phase 1 trial for SMARCA4 (BRG1) mutated ...